WSK-IM02 / WestVac Biopharma - LARVOL DELTA

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I) (clinicaltrials.gov) - P1 | N=9 | Not yet recruiting | Sponsor: WestVac Biopharma Co., Ltd.

New P1 trial • Oncology • Respiratory Diseases • Solid Tumor

A Phase 1, Single-arm, Single-center, Open-label, Prospective Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer (ChiCTR) - P1 | N=36 | Sponsor: West China Second University Hospital, Sichuan University; West China Second University Hospital, Sichuan University

New P1 trial • Platinum resistant • Oncology • Ovarian Cancer • Solid Tumor